FDA Inspection 1090843 — Szakacs Zoltan, Ph.D.

Szakacs Zoltan, Ph.D. — FEI 3015205433

The FDA completed an inspection of Szakacs Zoltan, Ph.D. on May 24, 2019 in Budapest Xiii. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Budapest Xiii (Hungary)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance